Display screen with graphical user interface for glucose monitoring system
Latest Roche Diabetes Care, Inc. Patents:
The broken lines showing in a portion of a display screen, text and other elements in the Figures are for illustrative purposes only and form no part of the claimed design.
Claims
The ornamental design for a display screen with graphical user interface for glucose monitoring system, as shown and described.
D392267 | March 17, 1998 | Mason |
D533872 | December 19, 2006 | Ligameri |
D543991 | June 5, 2007 | Vigesaa |
D593111 | May 26, 2009 | Danton |
D612398 | March 23, 2010 | Lemay |
D677269 | March 5, 2013 | Scott |
D684160 | June 11, 2013 | Truelove |
D701534 | March 25, 2014 | Jang |
D711906 | August 26, 2014 | Francisco |
D755804 | May 10, 2016 | Seo |
D768715 | October 11, 2016 | Park |
D769322 | October 18, 2016 | Rajeswaran |
D775138 | December 27, 2016 | van Os |
D777747 | January 31, 2017 | Derby |
D789417 | June 13, 2017 | Yamasaki |
20040172301 | September 2, 2004 | Mihai |
20070177803 | August 2, 2007 | Elias |
20100087230 | April 8, 2010 | Peh |
20140181650 | June 26, 2014 | Polubinski |
20150286386 | October 8, 2015 | Kaufthal |
20160212167 | July 21, 2016 | Dotan |
20180042559 | February 15, 2018 | Cabrera, Jr. |
- “Accuracy and . . . ” Aug. 10, 2016, posted at senseonics.com, [site visited Aug. 21, 2018]. http://www.senseonics.com/˜/media/Files/S/Senseonics-IR/docunnents/publications/accuracy-and-longevity-of-an-implantable-continous-glucose-sensor-in-the-precise-study-a-180-day-prospective-multi-center-pivotal-trial.pdf.
- Brown, Adam et al., “Dexcom G5 Mobile—CGM on Your Phone, Receiver Optional” Oct. 16, 2015, posted at diatribe.org, [site visited Aug. 21, 2018]. https://diatribe.org/dexcom-g5-mobile-cgm-your-phone-receiver-optional.
- “Bigfoot Biomedical Reveals Its Automated Insulin Delivery System!” Jan. 25, 2016, posted at diatribe.org, [site visited Aug. 21, 2018]. https://diatribe.org/bigfoot-biomedical-reveals-its-automated-insulin-delivery-system.
Type: Grant
Filed: Feb 14, 2017
Date of Patent: Jul 2, 2019
Assignee: Roche Diabetes Care, Inc. (Indianapolis, IN)
Inventor: Nils Babion (Heidelberg)
Primary Examiner: Jack Reickel
Assistant Examiner: John M Otte
Application Number: 29/593,962